Allergy Immunotherapy Market Size, Trends & Europe Dominance
The allergy immunotherapy market size is calculated at USD 2.31 bn in 2026 is to hit USD 4.90 bn by 2035. In 2024, Europe led the allergy immunotherapy market share of 68%, with subcutaneous immunotherapy dominating treatment types. The tablets segment held the largest market share, while the drops segment is expected to grow significantly. The allergy rhinitis segment led by allergy type, with hospital pharmacies dominating distribution channels.
Last Updated : 09 July 2026
Category: Therapeutic Area
Insight Code: 5411
Format: PDF / PPT / Excel